Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9
Given the implication of dopamine dysregulation and dopamine transporter in ADHD, we are curious about whether the D2R-DAT protein complex will prove to be a viable therapeutic target for ADHD
8 Challenges in clinical application Considering the enumerated benefits of GLP-1RA compared to other glucose-lowering drugs including the reduction in HbA1c and weight reduction benefits alongside decreased risk for hypoglycaemia (122) it is not cost effective if used in combination with another incretin (107)
Severe, persistent, or worsening abdominal pain, especially with vomiting or inability to eat or drink, needs medical attention
Worsening of Tourette's syndrome has also been reported [see Adverse Reactions (6.2)]
US$ 22.42
US$ 21.79
US$ 29.05
US$ 21.44
